Skip to main content
Earnings Labs
Rocket Pharmaceuticals, Inc. logo

Rocket Pharmaceuticals, Inc. (RCKT)

NASDAQ·Healthcare·Biotechnology

$2.32

-2.94%

Mkt Cap $261.81M

Analyst Ratings

Buy

7

Hold

1

Sell

0

Price Target (15 analysts)

$5.32

Range $2.95 – $9.00

Implied Upside

+129.3%

Consensus $5.32 vs current $2.32